Source: CREATV MICROTECH, INC. submitted to NRP
SAMPLE PREPARATION CHIP FOR PCR DETECTION OF WATER BORNE PATHOGENS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0203000
Grant No.
2005-33610-15595
Cumulative Award Amt.
(N/A)
Proposal No.
2005-00192
Multistate No.
(N/A)
Project Start Date
May 1, 2005
Project End Date
Dec 31, 2006
Grant Year
2005
Program Code
[8.4]- (N/A)
Recipient Organization
CREATV MICROTECH, INC.
11609 LAKE POTOMAC DR.
POTOMAC,MD 20854
Performing Department
(N/A)
Non Technical Summary
Enterohemorrhagic Escherichia coli (E. coli O157:H7) is a causative agent of food- and water-borne diseases. Newly developed rapid immunoassay- and PCR-based techniques have been used for detection of E. coli O157:H7 in water and food samples. However, they have proven inadequate, because of the large sample size, an insufficient number of pathogens in the sample, sample splitting, antibody cross reaction, and PCR inhibition caused by sample contaminants. We propose a rapid, sensitive, specific and quantitative test for water-borne pathogens. The method can be employed wherever PCR is used to determine the presence, concentration and/or genetic characteristics of bacterial or viral pathogens. Greatest benefit will be seen in the analysis of samples that are large in relation to the typical 2-5 microliter template volume for PCR, particularly for water quality, food safety, and environment tests. We will develop the method initially to detect E. coli O157:H7 in drinking water in Phase I and source and recreational waters in Phase II. The public will benefit greatly from safer drinking water, rivers and beaches.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7120210104050%
7120210110050%
Goals / Objectives
The objective of this SBIR project is to develop a detection method for water-borne pathogens. This method combines a proprietary sample preparation chip with multiplex real-time PCR to provide rapid, sensitive, specific and quantitative results. The method is applicable to a wide variety of water-borne pathogens. We will demonstrate that this method can eliminate PCR inhibition, minimize sample splitting, complete the test including pre-concentration in about three hours, determine specificity by six genes associated with E. coli O157:H7, and obtain sensitivity that meets EPA standards. Phase I will perform the proof-of-principle using E. coli O157:H7 in drinking water. Phase II will further improve the sample preparation method and detect E. coli O157:H7 in surface water.
Project Methods
The approach we are taking for the detection of water-borne pathogen is to utilize micro-fluidic chip to isolate and concentrate the bacteria from water sample, followed by cell-lysis and mutiplex real-time for strain identification. The details of the proposed approach is as below: Micro-fluidic chip. Immuno-concentration/purification chip to incorporate sonic turbulent mixing will be developed. The water sample will be circulated through a micro-fluidic chip. Sonic mixing will be employed to accelerate the capture process. The walls of the chip will be coated with specific monoclonal antibodies against the pathogen. This will selectively capture the target pathogen on the chip surface and simultaneously wash out the contaminants. The captured pathogens can be recovered in a small volume of lysis buffer for further genetic assays. Preparation of PCR template. The bacterial cells captured are directly lysed and centrifuged. The genomic DNA of E. coli O157:H7 in the supernatant is used as the template for quantitative and multiplex real-time PCRs. Real-time PCRs. Two types of real-time PCR assay will be applied in this study. (1) A quantitative real-time PCR will be used to determine genome copy numbers of E. coli O157:H7. The lacZ gene will be amplified as genetic marker and a standard curve of the lacZ gene will be constructed. The quantitative real-time PCR assay will be used to evaluate the capture efficiency of the micro-fluidic chip. (2) The multiplex real-time PCR will be used as the confirmation assays. Six genetic markers on the bacterial genome (16S rRNA, rfbEO157, flicH7, eaeA, stx1 and stx2) will be examined by multiplex real-time PCR for identifying the strain's classification and virulence. Specific primers and probes will be designed and synthesized. The protocols of multiplex real-time PCR will be developed and optimized in this Phase I study. The combination of proposed micro-fluidic chip and real-time PCRs will provides a rapid sample preparation, high sensitivity and specificity of the assays that will bring us a novel approach to detect water-borne pathogens.

Progress 05/01/05 to 12/31/06

Outputs
We designed and developed a sonic mixing flow cell, referred to hereafter as the sample preparation "flow cell". The flow cell used sonic mixing technology to disrupt laminar flow and improve the capture of E. coli by antibodies immobilized on the glass surface of the flow cell. We showed that mixing improved the capture efficiency, and the sonic mixing flow cell was able to capture 8% of the cells from a 10 ml sample in 45 min, in a flow cell volume of 900 ul. In an effort to reduce cost and complexity, we also developed another format of the sample preparation flow cell using capillary tubes and air bubbles to disrupt laminar flow and capture E. coli by antibodies immobilized on the surface of the capillary tube. Again, we showed that mixing improved the capture efficiency, and the air bubble format flow cell was able to capture 2% of the cells from a 5 ml sample in 1 hr, in a flow cell volume of 50 ul. Capture efficiency of 20% is predicted using a 500 ul flow cell. Preliminary data of the capillary flow cell shows that capillary flow cells can capture more cells than sonic mixing flow cell and provide more DNA copies for PCR. We have developed two simple and rapid DNA extraction methods that are able to extract the genomic DNA from the antibody-captured bacteria in both flow cells. The extracted DNA is subject to real-time PCR assays. We have successfully developed two real-time PCR assays. One is a quantitative real-time PCR assay to determine the numbers of E. coli cells that have been immuno-captured on the sonic mixing or capillary flow cells. The second assay is the multiplex real-time PCR assay for the confirmation and identification of E. coli O157:H7 serotypes and virulence factors. For the quantitative real-time PCR assay, a standard curve was first constructed using a plasmid standard containing E. coli lacZ gene. There was a strong linear inverse relationship (R2 = 0.9997) between threshold cycle (CT) and the log10 number of lacZ copies over 7 orders of magnitude. The equation describing the relationship is CT =−3.1998xlog10 (lacZ) + 39.54. A master mix of quantitative real-time PCR was prepared and optimized for the quantitative assays. For the multiplex real-time PCR assay, we have designed primers and probes to determine 5 genetic markers on the E. coli O157:H7 genome including the rfbEO157, fliCH7, stx1, stx2 and eaeA gene. The rfbEO157, and fliCH7 genes code for specific somatic and flagellar antigens associated with O157 and H7 serotypes, respectively. The stx1, stx2 and eaeA genes code for Shiga-Like Toxin I, Shiga-Like Toxin II, and Intimn outer membrane proteins responsible for bacterial pathogenesis. The primers and probes for these gene markers have been tested with a panel of 14 E. coli strains with different serotypes. The results obtained from the multiplex real-time PCR assays were consistent with that of serotyping, suggesting the primers and probes developed in this Phase I study were highly specific. In addition to quantification of E. coli O157:H7 cell numbers, our PCR assays are capable of confirming and identifying bacterial serotypes and virulence factors.

Impacts
The sample preparation flow cells, in conjunction with multiplex real-time PCR, reduces potential interference from PCR inhibitors, minimizes sample splitting, and provides high sensitivity and specificity for rapid detection of water-borne pathogens.

Publications

  • Zhu, P., Shelton, D. R., Karns, J. S., Sundaram, A., Li, S., Amstutz, P. and Tang, C.M.(2005) Detection of water-Borne E. coli O157 using the integrated waveguide biosensor, Biosens. Bioelectron. 21, 678-683.